Azithromycin versus doxycycline for genital chlamydial infections: A meta-analysis of randomized clinical trials

Sexually Transmitted Diseases

Volumn 29, Issue 9, 2002, Pages 497-502

  Lau, Chuen Yen ^a   Qureshi, Azhar K ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; DRUG TOLERANCE; FOLLOW UP; GENITAL TRACT INFECTION; HUMAN; META ANALYSIS; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME;

EID: 0037009047     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200209000-00001     Document Type: Article

References (41)

1. Incident Chlamydia trachomatis infections among inner-city adolescent females
2. Global prevalence and incidence estimates of selected curable STD's
3. National guideline for management of Chlamydia trachomatis genital tract infection
4. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
5. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
6. Guidelines for treatment of sexually transmitted diseases
7. Genital chlamydia infection
8. Chlamydial STD treatment
9. A controlled trial of single dose azithromycin for the treatment of chlamydial urethritis and cervicitis
10. Chlamydial cervicitis and urethritis: Single dose treatment compared with doxycycline for seven days in community based practices
11. Quantitative methods in the review of epidemiologic literature
12. Meta-analysis in clinical trials
13. Tests for publication bias in meta-analysis
14. Azithromycin as the first-line treatment of nongonococcal urethritis (NGU): A study of follow-up rates, contact attendance and patients' treatment preference
15. Azithromycin in the treatment of sexually transmitted disease
16. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males
17. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis
18. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents
19. Single-dose oral azithromycin versus seven day doxycycline in the treatment of nongonococcal urethritis in males
20. Comparison of azithromycin and doxycycline in the treatment of nongonococcal urethritis in men
21. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men
22. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men
23. Doxycycline and azithromycin for prevention of chlamydial persistence of recurrence one month after treatment in women: A use-effectiveness study in public health settings
24. An open label comparative study of Azithromycin and doxycycline in the treatment of nongonococcal urethritis in males and Chlamydia trachomatis cervicitis in female sex workers in an STD clinic in Singapore
25. Systematic reviews: Synthesis of best evidence for clinical decisions
26. Doxycycline in the treatment of chlamydial urethritis: A therapeutic study
27. A prospective single blind trial of minocycline and doxycycline in the treatment of genital Chlamydia trachomatis infection in women
28. Treatment of sexually transmitted chlamydial infections
29. Pivampicillin versus doxycycline in the treatment of chlamydial urethritis in men
30. Ciprofloxacin versus doxycycline in the treatment of uncomplicated urogenital Chlamydia trachomatis infections: A double-blind comparative study
31. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo
32. A double-blind comparison of erythromycin and doxycycline therapy for nongonococcal urethritis
33. Compliance with doxycycline therapy in sexually transmitted diseases clinics
34. Measured versus self-reported compliance with doxycycline therapy for chlamydia associated syndromes: High therapeutic success despite poor compliance
35. What is the minimally effective treatment for Chlamydia trachomatis infection? The compliance paradoxycycline
36. Treating chlamydial infection: Compliance versus cost
37. Doxycycline compared with azithromycin for treating women with genital chlamydia trachomatis infections: An incremental cost-effectiveness analysis
38. A cost-effectiveness analysis of screening, treatment for Chlamydia trachomatis infection in asymptomatic women